Overview

A Study of Mitoxantrone Hydrochloride Liposome Infusion

Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1/2, open-label, multicenter study.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Treatments:
Mitoxantrone